Viewing Study NCT00882869


Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2025-12-29 @ 1:01 PM
Study NCT ID: NCT00882869
Status: COMPLETED
Last Update Posted: 2011-07-13
First Post: 2009-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
Sponsor: Aegera Therapeutics
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-03
Start Date Type: None
Primary Completion Date: 2011-03
Primary Completion Date Type: ACTUAL
Completion Date: 2011-05
Completion Date Type: ACTUAL
First Submit Date: 2009-04-16
First Submit QC Date: None
Study First Post Date: 2009-04-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-07-12
Last Update Post Date: 2011-07-13
Last Update Post Date Type: ESTIMATED